Provention Bio, Inc.
PRVBNASDAQHealthcare
$24.98
+$0.00(+0.00%)
Market Cap$2.4B
P/E Ratio—
52W High$25.0
52W Low$3.185
Provention Bio, Inc. (PRVB) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRVB · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $165.00M | $127.13M | $121.82M | $85.37M | $58.54M |
| Net Receivables | $1.36M | $0.00M | $0.00M | $0.00M | $0.00M |
| Inventory | $1.23M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $174.65M | $101.10M | $126.55M | $86.00M | $61.53M |
| PP&E Net | $2.53M | $2.38M | $1.84M | $0.00M | $0.00M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $59.56M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $236.86M | $135.62M | $128.52M | ($75.22M) | $61.53M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $6.76M | $3.55M | $7.57M | $1.77M | $0.57M |
| Total Current Liabilities | $90.39M | $22.79M | $16.73M | $3.84M | $1.87M |
| Long-Term Debt | $23.91M | $0.59M | $0.71M | $0.00M | $0.00M |
| Total Liabilities | $115.01M | $24.89M | $306.16M | $3.84M | $1.87M |
| Stockholders Equity | |||||
| Retained Earnings | ($405.64M) | ($292.07M) | ($177.64M) | ($79.06M) | ($35.78M) |
| Total Stockholders Equity | $121.85M | ($292.07M) | ($177.64M) | ($79.06M) | $59.66M |
| Total Liab & Equity(computed) | $236.86M | ($267.19M) | $128.52M | ($75.22M) | $61.53M |
| Debt Summary | |||||
| Total Debt | $23.91M | $0.59M | $0.71M | $0.00M | $0.00M |
| Net Debt | ($20.13M) | ($77.60M) | ($101.58M) | ($39.16M) | ($58.54M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Provention Bio, Inc. data
About Provention Bio, Inc. (PRVB) Balance Sheet
Provention Bio, Inc. (PRVB) balance sheet shows total assets of $0.24B with cash of $0.17B. Total liabilities are $0.12B, total debt $0.02B, and stockholders equity $0.12B.
Frequently asked questions
PRVB · 4 questionsProvention Bio, Inc. has total debt of $0.02B with net debt of ($0.02B).
PRVB total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10